Literature DB >> 11901186

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

Peter Vajkoczy1, Mohammad Farhadi, Andreas Gaumann, Regina Heidenreich, Ralf Erber, Andreas Wunder, Jörg C Tonn, Michael D Menger, Georg Breier.   

Abstract

Tumors have been thought to initiate as avascular aggregates of malignant cells that only later induce vascularization. Recently, this classic concept of tumor angiogenesis has been challenged by the suggestion that tumor cells grow by co-opting preexisting host vessels and thus initiate as well-vascularized tumors without triggering angiogenesis. To discriminate between these two mechanisms, we have used intravital epifluorescence microscopy and multi-photon laser scanning confocal microscopy to visualize C6 microglioma vascularization and tumor cell behavior. To address the mechanisms underlying tumor initiation, we assessed the expression of VEGF, VEGF receptor-2 (VEGFR-2), and angiopoietin-2 (Ang-2), as well as endothelial cell proliferation. We show that multicellular aggregates (<< 1 mm(3)) initiate vascular growth by angiogenic sprouting via the simultaneous expression of VEGFR-2 and Ang-2 by host and tumor endothelium. Host blood vessels are not co-opted by tumor cells but rather are used as trails for tumor cell invasion of the host tissue. Our data further suggest that the established microvasculature of growing tumors is characterized by a continuous vascular remodeling, putatively mediated by the expression of VEGF and Ang-2. The results of this study suggest a new concept of vascular tumor initiation that may have important implications for the clinical application of antiangiogenic strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901186      PMCID: PMC150910          DOI: 10.1172/JCI14105

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  C6 glioma cell invasion and migration of rat brain after neural homografting: ultrastructure.

Authors:  J J Bernstein; W J Goldberg; E R Laws; D Conger; V Morreale; L R Wood
Journal:  Neurosurgery       Date:  1990-04       Impact factor: 4.654

2.  Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells.

Authors:  N Nagano; H Sasaki; M Aoyagi; K Hirakawa
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

4.  Determinants of human astrocytoma migration.

Authors:  A Giese; M D Rief; M A Loo; M E Berens
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

5.  Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.

Authors:  L F Brown; K Tognazzi; H F Dvorak; T J Harrist
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.

Authors:  K H Plate; G Breier; B Millauer; A Ullrich; W Risau
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

7.  Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium.

Authors:  A Vecchi; C Garlanda; M G Lampugnani; M Resnati; C Matteucci; A Stoppacciaro; H Schnurch; W Risau; L Ruco; A Mantovani
Journal:  Eur J Cell Biol       Date:  1994-04       Impact factor: 4.492

8.  Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox".

Authors:  M D Menger; S Pelikan; D Steiner; K Messmer
Journal:  Am J Physiol       Date:  1992-12

9.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.

Authors:  D Shweiki; M Neeman; A Itin; E Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

Authors:  G Breier; U Albrecht; S Sterrer; W Risau
Journal:  Development       Date:  1992-02       Impact factor: 6.868

View more
  64 in total

1.  scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis.

Authors:  Christopher R Anderson; Joshua J Rychak; Marina Backer; Joseph Backer; Klaus Ley; Alexander L Klibanov
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

2.  Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.

Authors:  Matthew D Budde; Eric Gold; E Kay Jordan; Melissa Smith-Brown; Joseph A Frank
Journal:  NMR Biomed       Date:  2011-09-22       Impact factor: 4.044

3.  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Authors:  Ralf Erber; Uta Eichelsbacher; Violetta Powajbo; Tobias Korn; Valentin Djonov; Jihong Lin; Hans-Peter Hammes; Rainer Grobholz; Axel Ullrich; Peter Vajkoczy
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

Review 4.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

5.  Zebrafish embryo model of Bartonella henselae infection.

Authors:  Amorce Lima; Byeong J Cha; Jahanshah Amin; Lisa K Smith; Burt Anderson
Journal:  Zebrafish       Date:  2014-07-15       Impact factor: 1.985

6.  Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.

Authors:  Peter Vajkoczy; Pjotr Knyazev; Andrea Kunkel; Hans-Holger Capelle; Sandra Behrndt; Hendrik von Tengg-Kobligk; Fabian Kiessling; Uta Eichelsbacher; Marco Essig; Tracy-Ann Read; Ralf Erber; Axel Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

7.  Effect of Weikangning on gastric cancer cell growth and expression of vascular endothelial growth factor and its receptors KDR and Flt-1.

Authors:  Qing-Ming Li; Fang-Ju Kan; Cun-Yun Min
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity.

Authors:  Jie Zhang; Ying Wang; Yang Wu; Zhen-Yu Ding; Xin-Mei Luo; Wu-Ning Zhong; Jie Liu; Xiang-Yu Xia; Guo-Hua Deng; Yao-Tiao Deng; Yu-Quan Wei; Yu Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-14       Impact factor: 4.553

9.  Computer simulation of glioma growth and morphology.

Authors:  Hermann B Frieboes; John S Lowengrub; S Wise; X Zheng; Paul Macklin; Elaine L Bearer; Vittorio Cristini
Journal:  Neuroimage       Date:  2007-03-23       Impact factor: 6.556

10.  Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastoma.

Authors:  Robert C Castellino; Benjamin G Barwick; Matthew Schniederjan; Meghan C Buss; Oren Becher; Dolores Hambardzumyan; Tobey J Macdonald; Daniel J Brat; Donald L Durden
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.